CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The PRESTIGE-AF project aims to determine the best antithrombotic prevention strategies for patients with atrial fibrillation who have survived intracerebral hemorrhage. It will conduct a randomized controlled trial to assess treatment effectiveness and develop personalized risk prediction tools.
Intracerebral hemorrhage (ICH) is a severe stroke subtype causing higher mortality and more disability than other strokes. 20% of ICH survivors have atrial fibrillation (AF), a major cause of ischemic stroke (IS).
While IS in AF patients is generally prevented by oral anticoagulants (OAC), their use in ICH survivors is uncertain due to increased bleeding risk.
No evidence from randomized controlled trials (RCT) is available addressing this dilemma.
Personalized risk prediction is desirable to ba…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT
Germany, Wurzburg
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Wuerzburg
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Austria, Graz
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, Birmingham
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
